Skip to main content
. Author manuscript; available in PMC: 2019 Oct 22.
Published in final edited form as: Mol Cancer Ther. 2016 Jul 25;15(9):2244–2250. doi: 10.1158/1535-7163.MCT-15-0879

Table 2.

Treatment-related toxicities

Toxicity Grade 1 Grade 2 Grade 3 Grade 4

Fatigue 5 6 1 0
Rash - acneiform, maculopapular 13 6 2 0
Dry skin 7 1 0 0
Skin infection/paronychia 1 2 1 0
Dehydration 0 0 1 0
Anorexia 1 1 1 0
Thromboembolic event 0 6 0 0
Anemia 8 4 2 0
Lymphopenia 11 9 1 0
Leukopenia/neutropenia 14 9 0 0
Thrombocytopenia 7 0 1 0
Nausea 5 2 0 0
Vomiting 4 1 0 0
Diarrhea 4 2 0 0
Constipation 2 0 0 0
Dry mouth/mucositis 4 1 0 0
Transaminase elevations (ALT/AST) 7 1 0 0
Hyperbilirubinemia 1 1 0 0
Renal insufficiency 1 0 1 0
Hypocalcemia 6 1 0 0
Hypokalemia 6 1 2 1
Hypomagnesemia 8 2 1 1
Hypophosphatemia 4 1 1 0
Edema of extremities 2 2 0 0
Fever 2 0 0 0
Infection 1 2 2 0
Dyspnea 0 3 0 0